TransAct Technologies Reports Preliminary First Quarter 2025 Financial Results
Sold Over 2,300 Terminals in the First Quarter 2025,
Total FST Revenue Up 49% Year-Over-Year
"We started the year with a solid first quarter, achieving an all-time, quarterly high of 2,350 BOHA! terminal unit sales, which drove a 49% year-over-year FST revenue growth, alongside an 18% increase in casino and gaming revenue, which came in at
First Quarter 2025 Financial Highlights
-
Net Sales : Net sales for the first quarter of 2025 were$13.1 million , up 28% sequentially and 22% compared to$10.7 million for the first quarter of 2024 as a result of stronger sales in both FST and gaming and casino. -
FST Recurring Revenue: FST recurring revenue for the first quarter of 2025 was
$2.7 million , which represents a slight decline of 3% sequentially but an increase of 10% compared to$2.4 million for the first quarter of 2024. -
Gross Profit: Gross profit for the first quarter of 2025 was
$6.4 million , resulting in gross margin of 48.7%, compared to gross profit of$5.6 million for the first quarter of 2024, resulting in a 52.6% gross margin. -
Operating loss: Operating loss for the first quarter of 2025 was
$(15) thousand , compared to an operating loss of$(1.1) million for the fourth quarter of 2024 and$(1.3) million for the first quarter of 2024. -
Net income (loss): Net income for the first quarter of 2025 was
$19 thousand , or$0.00 per diluted share, based on 10.1 million weighted average common shares outstanding. This compares to a net loss for the first quarter of 2024 of$(1.0) million , or$(0.10) per diluted share, based on 10.0 million weighted average common shares outstanding. -
EBITDA: EBITDA was
$221 thousand for the first quarter of 2025, compared to$(1.0) million for the fourth quarter of 2024 and$(1.0) million for the first quarter of 2024. -
Adjusted EBITDA: Adjusted EBITDA was
$544 thousand for the first quarter of 2025, compared to$(705) thousand in the fourth quarter of 2024, and$(701) thousand for the first quarter of 2024.
2025 Financial Outlook
-
Net Sales : The Company expects full year 2025 net sales of between$47 million and$52 million . -
Adjusted EBITDA: The Company expects full year 2025 adjusted EBITDA to be between
$0 (breakeven) and$(1.5) million .
Our outlook for non-GAAP adjusted EBITDA is presented only on a non-GAAP basis because not all of the information necessary for a quantitative reconciliation of this forward-looking non-GAAP financial measure to the most directly comparable GAAP financial measure is available without unreasonable effort, primarily due to uncertainties relating to the occurrence or amount of these adjustments that may arise in the future. If one or more of the currently unavailable items is applicable, some items could be material, individually or in the aggregate, to GAAP reported results.
Strategic Business Review
The Company’s Board of Directors and management have determined to suspend the Company’s strategic review process for now. Due to increasing levels of macroeconomic uncertainty and given the increased momentum in both the FST and Casino businesses, the Company intends to focus on incremental organic growth initiatives and investing in Company growth where most prudent. If and when conditions improve or opportunities arise, the Board will consider resuming the process. As always, the Board is committed to maximizing stockholder value and is constantly evaluating the best strategies to achieve that goal.
2025 First Quarter Conference Call and Webcast
TransAct is hosting a conference call and webcast today,
Interested parties may also access the conference call live on the Internet at www.transact-tech.com (select “Company” followed by “Investor Relations,” then select “News & Events” followed by “Events & Presentations”), or directly here. Approximately two hours after the call has concluded, an archived version of the webcast will be available for replay at the same location.
Non-GAAP Financial Measures
TransAct is providing certain non-GAAP financial measures because the Company believes that these measures are helpful to investors and others in assessing the ongoing nature of what the Company’s management views as TransAct’s core operations. EBITDA and adjusted EBITDA provide the Company with an understanding of one aspect of earnings before the impact of investing and financing charges and income taxes. The Company believes that these non-GAAP financial measures provide relevant and useful information to an investor evaluating the Company’s operating performance because these measures are: (i) widely used by investors to measure a company’s operating performance without regard to items that do not reflect the Company’s ongoing operations and are excluded from the calculation of such measures; (ii) used as financial measurements by lenders and other parties to evaluate creditworthiness; and (iii) used by the Company’s management for various purposes including strategic planning and forecasting and assessing financial performance. The presentation of this non-GAAP information is not considered superior to or a substitute for, and should be read in conjunction with, the financial information prepared in accordance with GAAP.
EBITDA is defined as net income (loss) before net interest income (expense), income taxes, depreciation, and amortization. A reconciliation of EBITDA to net income (loss), the most comparable GAAP financial measure, can be found attached to this release.
Adjusted EBITDA is defined as net income (loss) before net interest income (expense), income taxes, depreciation and amortization and is adjusted for (1) share-based compensation expense and (2) any other items, when they occur, that we believe do not reflect the ordinary earnings of the Company’s ongoing business. The Company adjusts EBITDA for share-based compensation because the Company considers share-based compensation expense to be a non-cash expense similar to depreciation and amortization. A reconciliation of adjusted EBITDA to net income (loss), the most comparable GAAP financial measure, can be found attached to this release.
About
©2025
Cautionary Statement Regarding Preliminary Financial Information
The Company has prepared the preliminary financial information set forth below on a materially consistent basis with its historical financial information and in good faith based upon its internal reporting as of and for the three months ended
This preliminary financial information should not be viewed as a substitute for full financial statements prepared in accordance with GAAP. In addition, this preliminary financial information is not necessarily indicative of the results to be achieved for any future period.
Forward-Looking Statements
Certain statements included in this press release include forward-looking statements within the meaning of the
- Financial tables follow-
|
|||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||
(Preliminary and Unaudited) |
|||
|
|
||
|
Three months ended
|
||
|
2025 |
|
2024 |
|
(In thousands, except per share data) |
||
|
|
|
|
Net sales |
|
|
|
Cost of sales |
6,694 |
|
5,063 |
Gross profit |
6,359 |
|
5,624 |
|
|
|
|
Operating expenses: |
|
|
|
Engineering, design and product development |
1,635 |
|
1,966 |
Selling and marketing |
2,085 |
|
2,083 |
General and administrative |
2,654 |
|
2,876 |
|
6,374 |
|
6,925 |
Operating loss |
(15) |
|
(1,301) |
|
|
|
|
Interest and other income (expense): |
|
|
|
Interest, net |
22 |
|
48 |
Other, net |
63 |
|
(60) |
|
85 |
|
(12) |
|
|
|
|
Income (loss) before income taxes |
70 |
|
(1,313) |
Income tax (expense) benefit |
(51) |
|
277 |
Net income (loss) |
|
|
|
|
|
|
|
Net income (loss) per common share: |
|
|
|
Basic |
|
|
|
Diluted |
|
|
|
|
|
|
|
Shares used in per share calculation: |
|
|
|
Basic |
10,043 |
|
9,972 |
Diluted |
10,054 |
|
9,972 |
SUPPLEMENTAL INFORMATION – SALES BY MARKET: |
|||
(Preliminary and Unaudited) |
|||
|
Three months ended
|
||
|
2025 |
|
2024 |
|
(In thousands) |
||
|
|
|
|
Food service technology |
|
|
|
POS automation |
618 |
|
651 |
Casino and gaming |
6,719 |
|
5,696 |
TransAct services group |
808 |
|
1,040 |
Total net sales |
|
|
|
|
|||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||
(Preliminary and Unaudited) |
|||
|
|
|
|
|
2025 |
|
2024 |
Assets: |
(In thousands) |
||
Current assets: |
|
|
|
Cash and cash equivalents |
|
|
|
Accounts receivable, net |
9,062 |
|
6,507 |
Inventories |
14,415 |
|
16,161 |
Prepaid income taxes |
402 |
|
401 |
Other current assets |
861 |
|
899 |
Total current assets |
38,918 |
|
38,362 |
|
|
|
|
Fixed assets, net |
1,645 |
|
1,818 |
Right-of-use assets, net |
905 |
|
1,141 |
|
2,621 |
|
2,621 |
Other assets |
75 |
|
92 |
|
5,246 |
|
5,672 |
Total assets |
|
|
|
|
|
|
|
Liabilities and Shareholders’ Equity: |
|
|
|
Current liabilities: |
|
|
|
Revolving loan payable |
|
|
|
Accounts payable |
4,670 |
|
4,569 |
Accrued liabilities |
3,105 |
|
3,253 |
Lease liabilities |
852 |
|
955 |
Deferred revenue |
1,125 |
|
1,107 |
Total current liabilities |
12,752 |
|
12,884 |
|
|
|
|
Deferred revenue, net of current portion |
335 |
|
246 |
Lease liabilities, net of current portion |
96 |
|
231 |
Other liabilities |
40 |
|
40 |
|
471 |
|
517 |
Total liabilities |
13,223 |
|
13,401 |
|
|
|
|
Shareholders’ equity: |
|
|
|
Common stock |
141 |
|
141 |
Additional paid-in capital |
58,414 |
|
58,141 |
Retained earnings |
4,534 |
|
4,515 |
Accumulated other comprehensive loss, net of tax |
(38) |
|
(54) |
|
(32,110) |
|
(32,110) |
Total shareholders’ equity |
30,941 |
|
30,633 |
Total liabilities and shareholders’ equity |
|
|
|
|
|
|
|
|
|||
RECONCILIATION OF NET INCOME (LOSS) TO EBITDA AND ADJUSTED EBITDA |
|||
NON-GAAP FINANCIAL MEASURES |
|||
(Preliminary and Unaudited) |
|||
|
|
|
|
|
Three Months Ended |
||
|
|
||
|
2025 |
|
2024 |
|
(In thousands) |
||
|
|
|
|
Net income (loss) |
|
|
|
|
|
|
|
Interest income, net |
(22) |
|
(48) |
Income tax expense (benefit) |
51 |
|
(277) |
Depreciation and amortization |
173 |
|
395 |
|
|
|
|
EBITDA |
221 |
|
(966) |
|
|
|
|
Share-based compensation expense |
323 |
|
265 |
|
|
|
|
Adjusted EBITDA |
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20250513865712/en/
Investor Contact:
Ryan.Gardella@icrinc.com
Source: